Actively Recruiting
Comparing Direct Selective Laser Trabeculoplasty and Standard SLT to Lower Eye Pressure in Open-Angle Glaucoma
Led by Medical University of South Carolina · Updated on 2026-05-06
172
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating two FDA-approved laser treatments for open-angle glaucoma and ocular hypertension Direct Selective Laser Trabeculoplasty DSLT and traditional Selective Laser Trabeculoplasty SLT. Both treatments aim to lower eye pressure to help prevent vision loss. DSLT is a newer, non-contact laser technique that may offer greater comfort and efficiency compared to the traditional SLT. This is a randomized controlled trial conducted by the Medical University of South Carolina to compare these two methods. Participants will be randomly assigned to receive either the Direct SLT or the Traditional SLT treatment. The Direct SLT uses a non-contact laser to target the eyes drainage system, while the Traditional SLT requires a lens placed on the eye to guide the laser. Both treatments are standard care and FDA approved. The study will follow participants for 12 months after treatment to monitor effects. During the study, participants will have their eye pressure measured at baseline and throughout the 12-month follow-up to assess changes. Researchers will evaluate treatment safety and effectiveness in lowering intraocular pressure. Participants will also be monitored for any side effects or complications related to the laser treatments. The total duration of involvement for each participant is approximately one year.
CONDITIONS
Brief Title
Direct vs Standard SLT for Glaucoma: A Noninferiority Trial
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here